SCAI shock modified stage B was not independently associated with an increased risk of in-hospital adverse events (OR 1.690) compared to modified stage A in patients with acute myocardial infarction.
Cohort (n=257)
No
Do in-hospital and long-term clinical outcomes differ between acute myocardial infarction patients categorized as SCAI shock stage B versus stage A?
Effect estimate: OR 1.690 (95% CI 0.747-3.826)
Absolute Event Rate: 15.6% vs 8.9%
p-value: p=0.208
Background: The mortality rate for acute myocardial infarction (AMI) complicated with cardiogenic shock (CS) remains high despite advances in mechanical circulatory support (MCS). The Society for Cardiovascular Angiography and Interventions (SCAI) has proposed a 5-stage classification of CS, and in this study we compared the clinical outcomes of AMI patients with SCAI shock stage A with those in stage B.
Sato et al. (Wed,) conducted a cohort in Acute Myocardial Infarction (AMI) (n=257). SCAI shock modified stage B vs. SCAI shock modified stage A was evaluated on In-hospital adverse events (composite of in-hospital death, initiation of mechanical circulatory support, and mechanical complications) (OR 1.690, 95% CI 0.747-3.826, p=0.208). SCAI shock modified stage B was not independently associated with an increased risk of in-hospital adverse events (OR 1.690) compared to modified stage A in patients with acute myocardial infarction.